The first global health emergency of the artificial intelligence era has revealed the surveillance system that China has been applying for some time, transforming it into a tool to fight the virus more effectively.
by
Alessandra Spalletta
24 June 2020
11 min read
by
Alessandra Spalletta
24 June 2020
11 min read
China is building an enormous facial recognition database that will identify its 1.3 billion citizens. In three seconds. In October 2017, an article in the South China Morning Post clarified the Beijing government’s ambitions. China is second only to the US for investments in Artificial Intelligence (AI). Above all, it is obsessed with security. These two aspects define the Chinese race to conquer global technological leadership. Three years on, intrusive technology has become the most powerful weapon in the hands of the Chinese to defeat the new coronavirus - which first emerged in Wuhan in late 2019.
The surveillance system is already widely used to track the movements of the virus and check that citizens are complying with social distancing rules. After an initial delay, China implemented draconian measures to defeat the “common enemy”, from building two emergency hospitals in ten days to closing schools and offices. Chinese president Xi Jinping identified the epidemic as the “most serious health emergency since the founding of the Republic”. He regained control of the narrative and the Chinese Communist Party (CCP) took credit for the victory - albeit still partial - in the “people's war” against the “demon”.
Last February, when the coronavirus broke out in the capital of Hubei, 11 million inhabitants were quarantined. They were joined by the residents of 15 other cities in the central Chinese region most affected by the epidemic: a total of 60 million people in lockdown. The West was soon to experience the same suffering, the same fear. The people of China made a huge sacrifice, giving up individual freedom without hesitation, said the Global Times director Hu Xijin. There was no lack of distrust, which was expressed in the gaps left open by an unusually intermittent censorship. However, in a country with a Taoist soul clothed in a Confucian habit, the people recognize the Party-State’s role as the guarantor of law and order. Faced with the risk of chaos, which the Chinese fear, the people follow the directives, aided by the cultural subordination of the individual to society.
In those first lockout days, one fear of a pragmatic nature haunted the Chinese: potential contact with people infected in the days preceding the outbreak of the virus. The solution to dispel all doubts was soon ready: China Mobile, the national telephone company, launched an app that allowed passenger movements over the previous thirty days to be reconstructed. These systems monitored the health of citizens who were unaware of being checked. The desire for reassurance overcame any timid resistance to the violation of privacy.
The World Health Organization repeatedly praised Beijing's management of the health emergency (amid repeated criticism of Chinese influence in the context of the WHO). At a press conference in Beijing last February, Bruce Aylward, a top virologist for the Geneva-based organization, called the Chinese approach “pragmatic” as it was “based on technology and science”. Taken up by state press agency Xinhua, he said: “The Chinese are making massive use of Big Data and Artificial Intelligence to track infections and offer online health consultations,” thus easing the pressure on hospitals. “AI has played a key role in the fight against Covid-19”, said the Deputy Minister of Science and Technology, Li Meng more recently.
The three private giants of the Chinese internet, Alibaba, Tencent, Baidu, enclosed in the collective BAT, sono da tempo al fianco delle autorità nella lotta alla criminalità e al dissenso politico. The technology developed in their headquarters is used in surveillance cameras installed in Chinese cities. The collaboration requested by Beijing – access to big data by law enforcement agencies - far exceeded that offered by Western technology giants to their governments. When Xi launched an appeal to technology companies last February to deal with the epidemic, Alibaba, Baidu and Tencent already had an arsenal of innovations ready to put in place: Big Data, Artificial Intelligence, robotics. A few examples.
China has assumed a dominant position in the world video surveillance market: with 200 million cameras installed across the country, it has long been conducting experiments that use facial recognition to track every movement of the population. The leader in this sector is Sense Time, a 6 billion dollar giant specialized in facial recognition. In China, “losing face” is the worst thing that can happen, and “making someone lose face” means ending up in a state of mutual, extreme, embarrassment: Chinese etiquette requires everyone always to be given the opportunity of a dignified exit. Who would have imagined that one day everyone would lose face, but without the burden of embarrassment, to perform a whole series of operations: in addition to allowing use of a smartphone, which has replaced cash and become a driving force for online purchases, in China facial recognition is customarily used to pay bills or enter your home. Now you can even do it wearing a mask.
Sense Time itself has developed a platform capable of scanning citizens wearing a mask. Contactless body temperature scanning software has been used in subway stations, schools and public centers in Beijing, Shanghai and Shenzhen. Another facial recognition company, Megvij, has developed a new system that can identify people with fever, using facial and body data. Infrared cameras are commercially available in the Chinese market, including those made by the company Zhejiang Dahua, which detect body temperature with an accuracy within 0.3 degrees. Baidu, China's biggest search engine, has also built them in its Artificial Intelligence Lab.
These companies operate within a well-oiled system, with State support for private companies to produce technologies that exploit access to personal data for purposes that may be questionable in terms of privacy, but are decidedly useful in a coronavirus pandemic. Simone Pieranni explains it well in his latest book “Red Mirror” (Laterza, 2020). Data are a gold mine: companies that have access to them can create sophisticated products that will sell abroad; the government comes to own valuable information on the movement of the population, thus strengthening its surveillance powers.
Reuters told a story - taken up by Pieranni in his book - that explains how the collaboration between operators and authorities, presented by the Chinese government as an effective service for combating Covid-19, has entered the private life of Chinese citizens. A gentleman from Hangzhou, a city located in southern China, returns home after a trip from Wenzhou: the red zone. As soon as he walks through the front door, he is contacted by the local police who urge him not to leave the house, to take his temperature, and to contact the health authorities if he has a fever. What happened? Video surveillance cameras recorded his license plate data. The police got hold of the information and it triggered the report. It doesn’t end here, because eventually the man from Hangzhou gets fed up of being locked up at home and decides to take a breath of fresh air. After a few minutes, he is contacted by his employer. This time, facial recognition cameras spotted the man near Hangzhou Lake, and the authorities also contacted the company.
Other examples. Police in Chengdu, the capital of the southwestern province of Sichuan, have used smart helmets capable of detecting body temperature. The helmet emits a kind of alarm when someone with a fever comes within 5 meters.
But the real snoops are smartphones: the power of the apps has allowed both the government and citizens to deal with the epidemiological crisis in an organized way. A primary example is the app for Alipay, Alibaba's financial arm, called Alipay Health Code. Used in over 200 cities, it assigns each citizen a different color, with red indicating people in supervised quarantine, yellow identifying people who are self-isolating and green indicating people who can enjoy freedom of movement. The app thus notifies users if they have come into contact with an infected person, selecting those who must stay at home and those who are instead allowed to attend public places.
Among the most invasive uses of Artificial Intelligence, one has been particularly highlighted by the western press. It concerns the use of drones to reproach unruly citizens; as in the video shot in Inner Mongolia, which went viral, in which an elderly lady is followed by a drone urging her to return home. Most of the drones in circulation are produced by a Shenzhen company called MMC (MicroMultiCopter).
AI has played a key role, especially on the main battlefield, the medical one, explains Xinhua. In hospitals, robots have replaced human beings in performing a series of tasks, from delivering meals and medicines to sick patients, to sanitizing environments. Robots created by another Shenzhen company, Pudu Technology, for example, have been deployed in over 40 healthcare facilities across China. Furthermore, thanks to artificial intelligence-based platforms, voice assistants allow 200 calls to be answered in five minutes.
Alibaba, the e-commerce giant, has developed an innovative swab that uses Artificial Intelligence to diagnose new cases of coronavirus in twenty minutes using computerized tomography scans (CT) with an accuracy rate of up to 96%. AI will also play a significant role in the search for new drugs. This was announced by the Cyberspace Administration of China, in an article that appeared on its website, entitled: “Artificial Intelligence and Big Data help research and development of new coronavirus drugs.”
Read more about Digital Transformation and Scientific Research
THIS WEBSITE (AND THE INFORMATION CONTAINED HEREIN) DOES NOT CONTAIN OR CONSTITUTE AN OFFER OF SECURITIES FOR SALE, OR SOLICITATION OF AN OFFER TO PURCHASE SECURITIES OR IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR FOR THE ACCOUNT OR BENEFIT OF ANY U.S. PERSON AS THAT TERM IS DEFINED IN THE SECURITIES ACT (A "U.S. PERSON"), AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH AN OFFER OR SOLICITATION WOULD REQUIRE THE APPROVAL OF LOCAL AUTHORITIES OR OTHERWISE BE UNLAWFUL (THE "OTHER COUNTRIES"). THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR PURSUANT TO THE CORRESPONDING REGULATIONS IN FORCE IN AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR THE “OTHER COUNTRIES” AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO A U.S. PERSON UNLESS THE SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS AVAILABLE. NO PUBLIC OFFERING OF SUCH SECURITIES IS INTENDED TO BE MADE IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR IN THE “OTHER COUNTRIES.”
In any Member State of the European Economic Area ("EEA"), the information contained in this website is only directed at and may only be communicated to persons who are "qualified investors" ("Qualified Investors") within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (the "Prospectus Regulation").
The information to which this website gives access is directed only at persons (i) who are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations etc.") of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (ii) who have professional experience in matters relating to investments falling within Article 19(5) of the Order or (iii) to whom it may otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which this communication relates is only available to relevant persons and will be engaged in only with relevant persons, or in the EEA, with Qualified Investors. Any person who is not a relevant person, a Qualified Investor or otherwise permitted under applicable law or regulation to access the information, should not act or rely on the information contained herein.
Confirmation of Understanding and Acceptance of Disclaimer
These materials are for informational purposes only and are not directed to, nor are they intended for, access by persons located or resident in the United States, Australia, Canada, Japan or South Africa or any of the Other Countries. I certify that:
I am not resident of, or located in, the United States, Australia, Canada, Japan or South Africa or any of the Other Countries or I am not a U.S. Person; or
If I am a resident of, or located in, the EEA, I am a Qualified Investor within the meaning of Article 2(e) of the Prospectus Regulation; or
If I am a resident of, or located in, the United Kingdom, I am a Qualified Investor and a relevant person.
I have read and understood the disclaimer set out above. I understand that it may affect my rights. I agree to be bound by its terms and I am permitted under applicable law and regulations to proceed to the following parts of this website.
WARNING: the above certification constitutes a "self-certification" pursuant to Decree of the President of the Italian Republic No. 445 of 28 December 2000. False certifications are punishable by law.
You must read the following information before continuing.
The information contained in this segment of the website is not intended for, and must not be accessed or distributed or disseminated to persons resident or physically present in the United Kingdom, Canada, Australia, Japan or any other jurisdiction in which it is unlawful to do so. The information also is not intended for, and must not be accessed or distributed or disseminated to persons resident or physically present in Italy who are not “qualified investors” (investitori qualificati), as defined in Article 2, letter e) of Regulation (EU) 2017/1129 (the “Prospectus Regulation”) pursuant to Article 1, fourth paragraph, letter a) of the Prospectus Regulation as implemented in Italy by Article 35, paragraph 1, letter d) of CONSOB regulation No. 20307 of February 15, 2018.
By clicking the button below labeled “I agree”, you are certifying that (A) if you are in the European Economic Area, you are a “Qualified Investor”; (B) you are not accessing this portion of the website from the United Kingdom, Australia, Canada or Japan; (C) if you are a resident or physically present in Italy, you are a qualified investor as defined under the Prospectus Regulation as implemented in Italy by Article 35, paragraph 1, letter d) of CONSOB regulation No. 20307 of February 15, 2018; and (D) you are not located in a jurisdiction where it is unlawful to access this portion of the website.
You acknowledge that the information and statements contained in the document you are accessing on this website speak only as of the date of such document (or such other date(s) specified therein), and such information and statements may become inaccurate, stale and/or out-of-date thereafter and should not be relied upon for any investment decision.
You acknowledge that the materials on this website that you are accessing are confidential and intended only for you and you agree you will not forward, reproduce, copy, download or publish any of such materials (electronically or otherwise) to any other person if this is not in accordance with the law.
You acknowledge that the access to information and documents contained on this portion of the website may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access this portion of the website. If you are not authorized to access the information and document contained on this portion of the website or you are not sure that you are permitted to view these materials, you should leave this portion of the website.
You acknowledge that no registration or approval has been obtained and Eni Gas e Luce S.p.A. società benefit and its affiliates assume no responsibility if there is a violation of applicable law and regulation by any person.
By clicking the button below labeled “I agree”, you are confirming that you have read and understood the disclaimer above.
If you cannot so confirm, you must exit this portion of the website